CN Patent

CN101879138A — 长春花生物碱纳米乳剂注射液及其制备方法

Assigned to Shanghai Hengrui Pharmaceutical Co Ltd · Expires 2010-11-10 · 16y expired

What this patent protects

本发明提供一种含有长春花生物碱，特别是含有长春瑞滨的纳米乳剂注射液及其制备方法，平均粒径小于100nm，既能减小长春瑞滨注射液的用药刺激性，又可以提高长春瑞滨在产品中的浓度，同时具有更高的靶向性。

USPTO Abstract

本发明提供一种含有长春花生物碱，特别是含有长春瑞滨的纳米乳剂注射液及其制备方法，平均粒径小于100nm，既能减小长春瑞滨注射液的用药刺激性，又可以提高长春瑞滨在产品中的浓度，同时具有更高的靶向性。

Drugs covered by this patent

Patent Metadata

Patent number
CN101879138A
Jurisdiction
CN
Classification
—
Expires
2010-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.